Chickpeas - disease management, Mid North

2015

Research organisatons
Funding sources

Trial details

Researcher(s) Jason Brand, Keshia Savage (DEDJTR), Christine Walela, Sarah Day, Amanda Pearce, Jenny Davidson, Andrew Ware, Larn McMurray (SARDI), Mark Richards, Eric Armstrong, Luke Gaynor, Karl Moore, Russell Pumpa and Jon Evans (NSW DPI)
Year(s) 2015
Contributor Southern Pulse Agronomy
Trial location(s) Turretfield, SA
Chickpeas - disease management, Mid North locations
Aims
  • To evaluate ascochyta blight (AB) response of new varieties by comparing their susceptibility to known varieties.
Key messages
  • There was no interaction between fungicide treatment and variety for grain yield across all varieties in this trial, a similar result to 2014 but opposed to that found in previous years. As in 2014 this result was surprising given the significant foliar disease infection observed in the susceptible varieties but was most likely due to the hot and very dry spring conditions which prevailed, halting disease progression and limiting grain yield. However, although interactions were not significant, it was noted that the line with the highest foliar AB infection level, Sonali, was the lowest yielding variety.
  • Although a significant treatment response was observed, there was only a 0.08 t/ha yield benefit from applying a fortnightly fungicide treatment as an average across all varieties. However, previous research shows varieties rated S and MS-MR will benefit from strategic fungicide applications during the growing season to control disease.
  • An update of the AB susceptibility rating for all chickpeas is under review following observations of foliar AB infection on GenesisTM 090 (rated as R) at multiple sites in SA and Victoria in 2015.
  • Due to the above finding and similar reports in commercial crops in SA in 2015, it is recommended that all chickpea varieties will require monitoring through the growing season for foliar AB infection and sprayed upon detection of disease to prevent spread to pods and seeds. All current chickpea varieties are susceptible to seed staining from AB, and require application of fungicides at the onset of podding. Varieties rated as MR and MS-MR will also benefit from strategic fungicide applications during the growing season to control disease.
Lead research organisation Department of Economic Development, Jobs, Transport and Resources VIC
Host research organisation N/A
Trial funding source DEDJTRVic
Trial funding source SARDI
Trial funding source GRDC DAV00113
Trial funding source DPI NSW
Related program Southern Pulse Agronomy
Acknowledgments

We sincerely want to thank and acknowledge all co-operators with whom we have worked with throughout the season, who have graciously allowed us to conducted trials on their land.

Technical support: 

  • Jason Ellifson Technical Officer, DEDJTR Horsham
  • Keisha Savage Technical Assistant, DEDJTR Horsham
  • Russel Argall Technical Officer, DEDJTR Horsham
  • Mick Brady Technical Officer, DEDJTR Mildura
  • Chris Davies Technical Assitant, DEDJTR Mildura
  • Henk Venter Technical Officer, Clare, SA
  • Cathy Fisher Technical Officer, Clare, SA
  • Lee Davis Technical Officer, Clare, SA
  • John Nairn Technical Officer, Clare, SA
  • Leigh Davis Technical Officer, Minnipa Ag Centre, SA

Other trial partners Pulse Breeding Australia, The University of Adelaide, Pulse Australia, Southern Farming Systems
Download the trial report to view additional trial information

Method

Crop type Chickpeas
Treatment type(s)
  • Fungicide
  • Fungicide: Application
  • Variety: Type
Trial type Experimental
Trial design Replicated

Turretfield 2015

Sow rate or Target density 35 plants/m2 (Kabuli), 50 plants/m2 (Desi)
Sow date Not specified
Harvest date Not specified
Plot size Not specified
Plot replication Not specified
Fertiliser

MAP + Zn (2%) @ 90 kg/ha at sowing

Download the trial report to view additional method/treatment information



CC BY
Individual Trial Project data and information and OFT metadata are licensed under a Creative Commons Attribution 4.0 International License.
The data and information accessed through OFT may also be subject to Terms of Use specified by the Trial Contributor,
in which case the Terms of Use of a Trial Contributor take precedence over other information provided on OFT.
Trial last modified: 26-06-2018 11:21am AEST